Structural Biology and Molecular Modeling Market 2028 By Product, Application and Geography | The Insight Partners

report image

Structural Biology and Molecular Modeling Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (SaaS and Stand-Alone Modeling Software, Databases, Visualization and Analysis Software, Others); Application (Drug Development, Drug Discovery, Others) and Geography

Report Code: TIPRE00003125 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming


Structural biology and molecular modelling are powerful tools for studying biological macromolecules' three-dimensional structure. Structural biology is the study of biological macromolecules' molecular structure and dynamics, particularly proteins and nucleic acids, and how structural changes affect their function. Structural biology is based on molecular biology, biochemistry, and biophysics principles. Drug development companies are investing in modelling projects that will allow them to predict the structure of newly developed drugs as well as the molecular components that will serve as biding sites. Hence, these molecular modeling tools have helped in better understanding of the concept of life.


The "Global Structural Biology and Molecular Modeling Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the structural biology and molecular modeling market with detailed market segmentation by product and application. The report provides key statistics on the market status of the leading structural biology and molecular modeling market players and offers key trends and opportunities in the market.


  •   Based on product the market is segmented as, Saas and stand-alone modeling software, database, visualization and analysis software and others.
  •   Based on application the market is segmented as, drug development, drug discovery and others.



  •   Growing in drug development procedures and rising demand for modeling techniques in order to perform feasibility studies to prevent study failures.
  •   Increasing prevalence of chronic diseases along with rising R&D studies to develop novel targeted therapies with structural biology and modeling techniques.
  •   Advancements in bioinformatics, molecular biology and modelling techniques are also expected to spur the market growth during the forecast period.


  •   However, involvement of high cost in R&D activities and dearth of skilled professionals are expected to restrain market growth.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The structural biology and molecular modeling market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the structural biology and molecular modeling market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.


The report covers key developments in the structural biology and molecular modeling market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from structural biology and molecular modeling market are anticipated to lucrative growth opportunities in the future with the rising demand for structural biology and molecular modeling in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the structural biology and molecular modeling market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Acellera Ltd.
  •   Dassault Systèmes
  •   Horiba
  •   Agilent Technologies, Inc.
  •   Illumina, Inc.
  •   Bruker
  •   Biomax Informatics AG
  •   Chemical Computing Group ULC
  •   Charles River Laboratories
  •   Thermo Fisher Scientific, Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies

1. Acellera Ltd.
2. Dassault Systèmes
3. Horiba
4. Agilent Technologies, Inc.
5. Illumina, Inc.
6. Bruker
7. Biomax Informatics AG
8. Chemical Computing Group ULC
9. Charles River Laboratories
10. Thermo Fisher Scientific, Inc
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount